← Back to Search

End-of-Life Planning for Cancer

N/A
Recruiting
Led By Jed Brubaker
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Study Summary

This trial will study how best to support people with terminal cancer and their loved ones as they make end-of-life plans.

Who is the study for?
This trial is for adults with metastatic cancer who have online accounts and data, as well as their adult family or friends willing to participate in end-of-life planning activities. There are no specific exclusion criteria listed.Check my eligibility
What is being tested?
The study focuses on the process of end-of-life planning concerning online accounts and data management for terminal cancer patients, involving their close ones in these preparations.See study design
What are the potential side effects?
Since this trial involves planning activities rather than medical interventions, there are no traditional side effects associated with it.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Determine best practices for supporting participants

Trial Design

1Treatment groups
Experimental Treatment
Group I: Post-Mortem PlanExperimental Treatment1 Intervention
Following the death of the terminally ill participant, investigators will work with networks as the wishes of the deceased are executed. Continued engagement at this point will allow us to provide support to the network during a difficult period or time while also identifying shortcomings in our plans and systemic challenges to postmortem planning. Working with those who are grieving is a delicate proposition, but one with which my students and I have extensive experience.

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,729 Previous Clinical Trials
2,143,392 Total Patients Enrolled
U.S. National Science FoundationFED
34 Previous Clinical Trials
8,574 Total Patients Enrolled
Jed BrubakerPrincipal InvestigatorUniversity of Colorado, Boulder

Media Library

Post-Mortem Plan Clinical Trial Eligibility Overview. Trial Name: NCT05222308 — N/A
Cancer Research Study Groups: Post-Mortem Plan
Cancer Clinical Trial 2023: Post-Mortem Plan Highlights & Side Effects. Trial Name: NCT05222308 — N/A
Post-Mortem Plan 2023 Treatment Timeline for Medical Study. Trial Name: NCT05222308 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the scope of involvement in this clinical experiment?

"Affirmative. Clinicaltrials.gov data confirms that the trial, which was unveiled on September 17th 2021, is currently recruiting participants. Approximately 300 individuals from 1 medical centre are required for this study."

Answered by AI

Is the subject pool of this clinical trial limited to those over 30 years old?

"This medical trial is recruiting participants aged 18 to 100. Additionally, there are 46 separate studies for minors and 706 distinct trials targeting elderly patients."

Answered by AI

What criteria must a person satisfy in order to qualify for enrollment in this clinical trial?

"This clinical trial is recruiting up to 300 individuals, aged 18-100 years old with metastatic cancer."

Answered by AI

Are there any open spots left in this clinical experiment?

"Affirmative. According to the information on clinicaltrials.gov, this research is currently searching for volunteers and was originally posted on September 17th 2021, with its most recent update being February 2nd 2022. The experiment necessitates 300 subjects enrolled at a single location."

Answered by AI
~136 spots leftby May 2026